Sudeep Pharma IPO subscribed 94 times as QIB demand drives strong bidding
Sudeep Pharma’s IPO saw robust interest with overall subscription at 93.72 times, led by exceptionally strong QIB participation. Non-institutional investors also showed high demand, while retail participation remained comparatively moderate. The ₹800 crore issue carries a price band of ₹563–593 per share.
By Finblage Editorial Desk
7:00 pm
25 November 2025
Sources & Disclaimer
This article is compiled from publicly available information, including company disclosures, stock exchange filings, regulatory announcements, and reports from global and domestic financial publications. The content has been editorially reviewed and enhanced by the Finblage Editorial Desk for clarity and investor awareness purposes only.
All information provided on Finblage is strictly for educational and informational use and should not be considered as financial, investment, legal, or professional advice. Readers are advised to conduct their own independent research and consult a certified financial advisor before making any investment decisions. Finblage shall not be held responsible for any losses arising from the use of information published on this website.
_edited.png)





